Immunitetni nazorat qilish punkti ingibitorlari saraton hujayralariga qarshi kurashish uchun tananing immun tizimi bilan kurashadigan dorilar sinfidir. Biroq, ko'pchilik bemorlar ushbu terapiyaga javob bermaydilar. Tananing o'smalarga qarshi immunitetini bostirishda ishtirok etadigan ikkita oqsilga qaratilgan yangi dori klassi mavjud.
Phase I of clinical trials has shown some exciting results, which were conducted in 19 patients suffering from rak with the molecule M7824. These researchers are also undertaking trials with those suffering from pankreatik saraton and those infected with HPV.
There are many other trials and experiments being taken to treat and saratonni davolash more effectively in different research institutes. This drug with a dual approach will be a boon in the saraton kasalligini davolash, as with a single molecule, multiple therapies are included.
